Inhibition of the DPP-4 enzyme played an important role in controlling the phenotypes of severe diseases, such as diabetes, obesity, and cancer, by preventing the inhibition of incretin hormones [10,11,12]. This evidence concerns the gene DPP4 and obesity due to melanocortin 4 receptor deficiency.